Page 99 - AN-3-2
P. 99

Advanced Neurology                                          Genetics of neurodevelopmental disorders in Mexico



               neuropathy. J Neuroophthalmol. 2021;41(3):e293-e296.  25.  Dumois-Petersen S, Gallegos-Arreola MP, Magaña-
                                                                  Torres   MT, Perea-Díaz FJ, Ringman JM, Figuera LE.
               doi: 10.1097/WNO.0000000000001012
                                                                  Autosomal dominant early onset Alzheimer’s disease in the
            18.  Vlaskamp DR, Shaw BJ, Burgess R,  et al. SYNGAP1   Mexican state of Jalisco: High frequency of the mutation
               encephalopathy: A distinctive generalized developmental and   PSEN1 c.1292C>A and phenotypic profile of patients. Am J
               epileptic encephalopathy. Neurology. 2019;92(2):e96-e107.  Med Genet C Semin Med Genet. 2020;184(4)1023-1029.
               doi: 10.1212/WNL.0000000000006729                  doi: 10.1002/ajmg.c.31865
            19.  Zhou J, Hamdan H, Yalamanchili HK,  et al. Disruption   26.  Murrell J, Ghetti B, Cochran E, et al. The A431E mutation
               of   MeCP2-TCF20   complex  underlies  distinct    in PSEN1 causing familial Alzheimer’s disease originating
               neurodevelopmental disorders. Proc Natl Acad Sci U S A.   in Jalisco State, Mexico: An additional fifteen families.
               2022;119(4):e2119078119.                           Neurogenetics. 2006;7(4):277-279.
               doi: 10.1073/pnas.2119078119                       doi: 10.1007/s10048-006-0053-1
            20.  Jakimiec M, Paprocka J, Śmigiel R. CDKL5 deficiency   27.  Hurtado-Jiménez R, Gardea-Torresdey J. Evaluation of the
               disorder-a complex epileptic encephalopathy.  Brain Sci.   exposure to selenium in the Highlands of Jalisco, Mexico.
               2020;10(2):107.                                    Salud Publica Mex. 2007;49(4):312-315.
               doi: 10.3390/brainsci10020107                      doi: 10.1590/S0036-36342007000400011
            21.  Reijnders MR, Janowski R, Alvi M, et al. PURA syndrome:   28.  Hurtado-Jiménez R, Gardea-Torresdey JL. Arsenic in
               Clinical delineation  and  genotype-phenotype  study in  32   drinking water in the Los Altos de Jalisco region of Mexico.
               individuals with review of published literature. J Med Genet.   Rev Panam Salud Publica. 2006;20(4):236-247.
               2018;55(2):104-113.                                doi: 10.1590/S1020-49892006000900004
               doi: 10.1136/jmedgenet-2017-104946              29.  Tata BK, Harbulot C, Csaba Z, Peineau S, Jacquier S, De
            22.  Mihaylova V, Müller JS, Vilchez JJ,  et al. Clinical and   Roux N. Rabconnectin-3α is required for the morphological
               molecular genetic findings in COLQ-mutant congenital   maturation of GnRH neurons and kisspeptin responsiveness.
               myasthenic syndromes. Brain. 2008;131(3):747-759.  Sci Rep. 2017;7:42463.
               doi: 10.1093/brain/awm325                          doi: 10.1038/srep42463
            23.  Schreiner F, Hoppenz M, Klaeren R, Reimann J, Woelfle  J.   30.  Stefanski A, Calle-López Y, Leu C, Pérez-Palma E, Pestana-
               Novel COLQ mutation 950delC in synaptic congenital   Knight E, Lal D. Clinical sequencing yield in epilepsy, autism
               myasthenic syndrome and symptomatic heterozygous   spectrum disorder, and intellectual disability: A systematic
               relatives. Neuromuscul Disord. 2007;17(3):262-265.  review and meta-analysis. Epilepsia. 2021;62(1):14.
               doi: 10.1016/j.nmd.2006.11.010                     doi: 10.1111/epi.16755
            24.  Torres C. Matrimonio entre parientes. Causas y causales de   31.  Fatkin D, Johnson R. Variants of uncertain significance
               dispensa en la parroquia de La Encarnación, 1778-1822. In:   and  “Missing  Pathogenicity.”  J Am Heart Assoc.
               Letras Históricas. Sacramento, CA: Creative Media Partners,   2020;9(3):e015588.
               LLC; 2015.                                         doi: 10.1161/JAHA.119.015588


























            Volume 3 Issue 2 (2024)                         13                               doi: 10.36922/an.3359
   94   95   96   97   98   99   100   101   102   103   104